Royal Bank of Canada »

Apellis Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.3M 142k 30.41
2024-06-30 $5.1M 133k 38.28
2024-03-31 $6.2M 101k 61.11
2023-12-31 $7.1M 118k 60.00
2023-09-30 $4.3M 119k 36.29
2023-06-30 $13M 141k 91.10
2022-12-31 $5.3M 103k 51.71
2022-09-30 $5.1M 74k 69.08
2021-06-30 $5.5M 86k 63.64
2021-03-31 $3.8M 88k 42.86
2020-12-31 $4.7M 84k 56.73
2020-09-30 $2.8M 92k 30.00
2020-06-30 $2.4M 73k 33.33
2020-03-31 $2.0M 74k 26.55
2019-12-31 $2.3M 77k 30.67
2019-09-30 $1.8M 77k 23.33
2019-03-31 $1.8M 90k 20.00
2018-12-31 $1.0M 77k 13.33
2018-09-30 $880k 49k 17.88
2018-06-30 $164k 5.7k 28.57
2018-03-31 $0 2 0.00
2017-12-31 $2.0k 98 20.41